BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lowered its position in Cooper Companies Inc (NYSE:COO) by 62.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,979 shares of the medical device company’s stock after selling 33,813 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Cooper Companies were worth $4,737,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in COO. AMP Capital Investors Ltd lifted its position in shares of Cooper Companies by 1.5% during the 3rd quarter. AMP Capital Investors Ltd now owns 20,264 shares of the medical device company’s stock valued at $4,804,000 after acquiring an additional 300 shares during the period. Engineers Gate Manager LP acquired a new stake in shares of Cooper Companies during the 3rd quarter valued at approximately $2,400,000. Synovus Financial Corp lifted its position in shares of Cooper Companies by 7.2% during the 3rd quarter. Synovus Financial Corp now owns 9,550 shares of the medical device company’s stock valued at $2,266,000 after acquiring an additional 638 shares during the period. Stifel Financial Corp lifted its position in shares of Cooper Companies by 10.9% during the 3rd quarter. Stifel Financial Corp now owns 12,065 shares of the medical device company’s stock valued at $2,857,000 after acquiring an additional 1,181 shares during the period. Finally, Pinebridge Investments L.P. acquired a new stake in shares of Cooper Companies during the 3rd quarter valued at approximately $565,000. Hedge funds and other institutional investors own 96.79% of the company’s stock.

A number of research analysts have recently weighed in on the stock. Jefferies Group set a $250.00 price objective on shares of Cooper Companies and gave the stock a “buy” rating in a research note on Thursday, August 17th. Zacks Investment Research cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, August 21st. Cleveland Research reissued a “buy” rating on shares of Cooper Companies in a research note on Tuesday, August 22nd. Robert W. Baird reissued a “buy” rating and set a $251.00 price objective on shares of Cooper Companies in a research note on Thursday, August 24th. Finally, KeyCorp reissued a “hold” rating on shares of Cooper Companies in a research note on Monday, August 28th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $259.70.

Shares of Cooper Companies Inc (COO) opened at $224.19 on Thursday. The company has a market cap of $11,238.75, a P/E ratio of 23.62, a price-to-earnings-growth ratio of 1.85 and a beta of 0.54. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. Cooper Companies Inc has a 12 month low of $172.83 and a 12 month high of $256.39.

Cooper Companies (NYSE:COO) last released its earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.64 by $0.01. The firm had revenue of $561.50 million during the quarter, compared to analysts’ expectations of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. Cooper Companies’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.28 EPS. equities analysts anticipate that Cooper Companies Inc will post 11.51 earnings per share for the current fiscal year.

WARNING: “Cooper Companies Inc (COO) Position Reduced by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/14/cooper-companies-inc-coo-position-reduced-by-british-columbia-investment-management-corp.html.

Cooper Companies Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related stocks with our FREE daily email newsletter.